Calcium
ApprovedSmall molecule
Eli LillyCalcium is a mineral that your body needs for strong bones and teeth, and it also helps your muscles and nerves work properly. It's used to treat or prevent calcium deficiency and to support bone health.[2] Calcium is currently approved and in use across 25 indications[4].[1]
Calcium is one of 576 small molecule programs targeting Systemic Lupus Erythematosus. It is currently in Approved.
25
Indications
25
Total Trials
3
Active Trials
575
Competitors
Pipeline
Status by Indication[4][1]
Indication
Showing 10 of 24 indications
Competition
Competitive Landscape
2828 competitors in Breast Cancer
#DrugCompanyPhaseTrials
1Calcium
Eli LillyApproved
Prolia
AmgenPreclinical
Gemzar
GGynecologic Oncology Group
Preclinical
Megace
Bristol-Myers SquibbPreclinical
Cymbalta
Alnylam PharmaceuticalsPreclinical
Adenocard
AstellasPreclinical
Methylthioninium Chloride
PProvepharm SAS
Preclinical
Sporanox
SSebela Pharmaceuticals Development LLC
Preclinical
Chantix
PPrism Pharmaceuticals
Preclinical
Nubain
AAultman Health Foundation
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Treatment2 trials
Musculoskeletal1 trial
18 more indications
Colorectal Cancer1 trial
Study of Folic Acid, Calcium and Vitamin D in Preventing Colorectal Polyps and Colorectal Cancer
Unknown status·SShanghai Jiao Tong University School of Medicine·Phase 2/3·NCT02066688·2,400 enrolled
Hypoparathyroidism1 trial
Osteoporosis1 trial
Atrial Fibrillation1 trial
Hypocalcemia1 trial
Ovarian Hyperstimulation Syndrome1 trial
Calcium for Prevention of Ovarian Hyperstimulation Syndrome
Completed·—·Phase 3·NCT01427335·200 enrolled
Oxytocin1 trial
Cirrhosis1 trial
Sources
References
- [1]
- [2]MedlinePlus Drug Information — Calcium drug information. U.S. National Library of Medicine, National Institutes of Health.
- [3]
- [4]Open Targets Platform — Drug–disease associations for Calcium. EMBL-EBI & Wellcome Sanger Institute.
- [5]